This inventor holds 1 USPTO granted patent. Top assignee: Sanofi Winthrop Inc.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Gurdial Singh Sandhu: Innovator in Antitumor Agents
Introduction
Gurdial Singh Sandhu is a notable inventor based in Northumberland, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. His innovative work has led to the creation of a unique formulation aimed at treating mammalian tumors.
Latest Patents
Gurdial Singh Sandhu holds a patent for "Lyophilized thioxanthenone antitumor agents." This patent discloses reconstituted lyophilized formulations that combine a thioxanthenone antitumor agent with mannitol or sucrose as a stabilizer in a lactate buffer. This formulation represents a significant advancement in the treatment of tumors.
Career Highlights
Sandhu is currently associated with Sanofi Winthrop Inc., a prominent company in the pharmaceutical industry. His work at Sanofi Winthrop has allowed him to focus on innovative solutions for cancer treatment. His dedication to research and development has positioned him as a key player in his field.
Collaborations
One of his notable collaborators is Stephen Brown. Together, they have worked on various projects aimed at enhancing the efficacy of antitumor therapies. Their partnership exemplifies the collaborative spirit that drives innovation in the pharmaceutical sector.
Conclusion
Gurdial Singh Sandhu's contributions to the development of antitumor agents highlight his commitment to advancing medical science. His innovative formulations and collaborations continue to pave the way for new treatments in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile